ArticleJournal of gastrointestinal oncology2026

Comparable survival outcome with anti-EGFR therapy in any treatment line in left-sided metastatic colorectal cancer.

Anita Archwamety et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.